Pharmacology A Patient Centered Nursing Process Approach 8th Edition-Kee -Hayes
Pharmacology A Patient Centered Nursing Process Approach 8th Edition-Kee -Hayes
$2.99
Chapter 35: HIV- and AIDS-Related Drugs
Complete Chapter Questions With Answers
Sample Questions Are Posted Below
MULTIPLE CHOICE
| a. | has an increased risk of transmitting the HIV infection. |
| b. | is less likely to develop AIDS than younger persons with HIV infection. |
| c. | is less likely to respond to antiretroviral agents. |
| d. | may have comorbid illnesses that can complicate HIV. |
ANS: D
Older HIV-infected patients may have age-related comorbid illness that can complicate management of HIV infection.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: Page 470
TOP: NURSING PROCESS: Assessment
MSC: NCLEX: Physiological Integrity: Pathophysiology
| a. | acute retroviral syndrome. |
| b. | AIDS. |
| c. | an increased viral load. |
| d. | an opportunistic infection. |
ANS: A
Acute retroviral syndrome often occurs 2 to 12 weeks after exposure and is caused by rapid viral replication that triggers an immune response, resulting in CD4 cell replacement and HIV antibody production that causes the viral load to drop. This patient is experiencing symptoms of this syndrome. AIDS is a diagnosis that indicates advanced disease. Opportunistic infection symptoms are related to the type of infection.
DIF: COGNITIVE LEVEL: Understanding (Comprehension) REF: Page 470
TOP: NURSING PROCESS: Assessment
MSC: NCLEX: Physiological Integrity: Pathophysiology
| a. | A drug-resistant strain is likely. |
| b. | The patient is progressing as expected. |
| c. | The patient’s treatment goals have been met. |
| d. | Treatment failure has occurred. |
ANS: B
The treatment goal would be a VL of < 20 copies/mL and a CD4 cell count between 800 and 1200 cells/mm3. This goal should be achieved in 16 to 24 weeks. Since this patient has shown improvement, progress has been made, and treatment should continue. A drug-resistant strain is not likely to respond to therapy. Treatment failure is not evident.
DIF: COGNITIVE LEVEL: Applying (Application) REF: Page 470
TOP: NURSING PROCESS: Evaluation
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
| a. | Abacavir/lamivudine/zidovudine (Trizivir) |
| b. | Efavirenz/emtricitabine/tenofovir (Atripla) |
| c. | Lamivudine/zidovudine (Combivir) |
| d. | Rilpivirine/emtricitabine/tenofovir (Complera) |
ANS: C
Antiretroviral therapy is strongly recommended for all pregnant HIV-infected patients. The preferred dual nucleoside reverse transcriptase inhibitor is Combivir.
DIF: COGNITIVE LEVEL: Applying (Application) REF: Page 474
TOP: NURSING PROCESS: Planning
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
$25.00 Original price was: $25.00.$15.00Current price is: $15.00.
$90.00 Original price was: $90.00.$60.00Current price is: $60.00.
$30.00 Original price was: $30.00.$20.00Current price is: $20.00.
$30.00 Original price was: $30.00.$20.00Current price is: $20.00.
$30.00 Original price was: $30.00.$20.00Current price is: $20.00.
$200.00 Original price was: $200.00.$150.00Current price is: $150.00.
511 SW 10th Ave 1206, Portland, OR, United States